Stifel's stock drops after big miss on Q3 earnings estimate partly due to non-recurring legal accruals
Stifel Financial Corp.'s stock (SF) dropped 5.7% on Wednesday after the investment bank and financial services company's third-quarter earnings of 60 cents a share missed the FactSet consensus estimate of $1.29 a share. Stifel also had non-recurring legal costs of 58 cents a share related to the industry review by the U.S. Securities and Exchange Commission of off-channel communications. Adding that cost back into its earnings would have brought the figure up to $1.18 a share. Revenue of $1.05 billion fell short of the analyst forecast of $1.07 billion. Stifel Chief Executive Ronald J. Kruszewski said the company's results were solid despite challenging market conditions. "Although the near-term environment remains uncertain, we remain well positioned to generate stable returns and strong growth as the market improves," he said.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-25-23 1135ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters